We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.8B
AUM Growth
-$421M
Cap. Flow
-$543M
Cap. Flow %
-11.33%
Top 10 Hldgs %
11.23%
Holding
2,126
New
460
Increased
575
Reduced
566
Closed
461

Sector Composition

Rank Sector Weight
1 Technology 16.81%
2 Consumer Discretionary 14.52%
3 Healthcare 12.46%
4 Industrials 12.28%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PKD
1651
DELISTED
Parker Drilling Company
PKD
$58K ﹤0.01%
+19,303
New +$79.5K
LITS
1652
Lite Strategy Inc
LITS
$30.9M
$56K ﹤0.01%
+650
New +$53.2K
BCIC
1653
BCP Investment Corp
BCIC
$92.9M
$56K ﹤0.01%
1,684
-4,406
-72% -$143K
GLACW
1654
DELISTED
Greenland Acquisition Corporation Warrant
GLACW
$52K ﹤0.01%
+190,875
New +$41.2K
SRRA
1655
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$51K ﹤0.01%
+737
New +$66.8K
NRXPW
1656
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$47K ﹤0.01%
105,000
TCON
1657
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$45K ﹤0.01%
104
-155
-60% -$71.8K
XFOR icon
1658
X4 Pharmaceuticals
XFOR
$460M
$43K ﹤0.01%
+137
New +$58.1K
TOTAW
1659
DELISTED
Tottenham Acquisition I Limited Warrant
TOTAW
$40K ﹤0.01%
+200,000
New +$39.3K
BCACW
1660
DELISTED
Bison Capital Acquistion Corp Warrant
BCACW
$39K ﹤0.01%
75,000
GEN
1661
DELISTED
Genesis Healthcare, Inc.
GEN
$35K ﹤0.01%
25,171
-16,008
-39% -$25.4K
FCSC
1662
DELISTED
Fibrocell Science Inc.
FCSC
$28K ﹤0.01%
+11,671
New +$25.2K
TURN
1663
DELISTED
180 Degree Capital
TURN
$22K ﹤0.01%
3,424
-3,405
-50% -$23K
SCYX icon
1664
SCYNEXIS
SCYX
$52M
$16K ﹤0.01%
+166
New +$19.6K
GAU
1665
Galiano Gold
GAU
$538M
$9K ﹤0.01%
+10,884
New +$10.2K
ABEV icon
1666
Ambev
ABEV
$46.4B
-578,475
Closed -$2.7M
ACHC icon
1667
Acadia Healthcare
ACHC
$2.94B
-44,436
Closed -$1.81M
AIV
1668
Aimco
AIV
$383M
-243,296
Closed -$1.37M
AKBA icon
1669
Akebia Therapeutics
AKBA
$252M
-116,062
Closed -$1.12M
ALV icon
1670
Autoliv
ALV
$9B
-13,339
Closed -$1.38M
AM icon
1671
Antero Midstream
AM
$10.1B
-55,110
Closed -$1.03M
OSG
1672
Octave Specialty Group
OSG
$222M
-40,606
Closed -$809K
AMRN
1673
Amarin Corp
AMRN
$303M
-656
Closed -$40K
AMRX icon
1674
Amneal Pharmaceuticals
AMRX
$5.79B
-108,303
Closed -$1.79M
ANSS
1675
DELISTED
Ansys
ANSS
-3,338
Closed -$577K

Similar funds

Oxford Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Oxford Asset Management held 2,126 positions worth $4.8B, down 8.1% from $5.22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Oxford Asset Management withdrew a net $543M in Q3 2018, closing 461 positions and reducing 566 holdings. Its most notable exit was Cavium, Inc., an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in CA, Inc. worth $72.4M.

  • Oxford Asset Management's largest Q3 2018 buy was CA, Inc.: 1,645,180 shares worth $72.4M.
  • Oxford Asset Management added most to GTY Technology Holdings, Inc. Common Stock in Q3 2018, an estimated $26.6M increase.
  • Oxford Asset Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $85.7M.
  • Oxford Asset Management fully exited Cavium, Inc. in Q3 2018, selling an estimated $166M.
  • Oxford Asset Management's ten largest holdings make up 11% of its $4.8B portfolio in Q3 2018.
  • Oxford Asset Management opened 460 new positions and closed 461 in Q3 2018.
  • Oxford Asset Management's portfolio value fell 8.1% quarter-over-quarter to $4.8B.

Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.